CAPTRUST Financial Advisors’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108K Buy
17,012
+6,446
+61% +$44.9K ﹤0.01% 2802
2025
Q4
$74.4K Sell
10,566
-1,125
-10% -$6.79K ﹤0.01% 2642
2025
Q3
$64.3K Buy
+11,691
New +$57.3K ﹤0.01% 2545
2022
Q3
Sell
-671
Closed -$4K 3159
2022
Q2
$4K Buy
671
+566
+539% +$4.33K ﹤0.01% 4190
2022
Q1
$1K Buy
105
+86
+453% +$755 ﹤0.01% 4709
2021
Q4
$0 Sell
19
-234
-92% -$2.48K ﹤0.01% 4844
2021
Q3
$4K Buy
+253
New +$4.87K ﹤0.01% 4037

Other funds holding LFST

CAPTRUST Financial Advisors's LFST Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its Lifestance Health (LFST) stake by 61% in Q1 2026, buying an estimated $44.9K and bringing the position to 17,012 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #2802.

CAPTRUST Financial Advisors first reported a position in LFST in Q3 2021 and has held it in 7 quarters since. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • CAPTRUST Financial Advisors held 17,012 shares of Lifestance Health worth $108K as of Q1 2026.
  • CAPTRUST Financial Advisors bought 6,446 Lifestance Health shares in Q1 2026, an estimated $44.9K.
  • Lifestance Health made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2802 holding.
  • CAPTRUST Financial Advisors first reported a position in Lifestance Health in Q3 2021 and has held it in 7 quarters since.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.